While there are a number of treatments available for diabetic kidney disease (DKD), the biggest limitation is the lack of early detection, said Daniel E. Weiner, MD, MS, board certified nephrologist and lead navigator at Tufts Clinical and Translational Science Institute.
"None of the systems that are in place right now are designed to detect early stage kidney disease and prevent something from happening 5, 10, 20 years down the road," said Daniel E. Weiner, MD, MS, board certified nephrologist and lead navigator at Tufts Clinical and Translational Science Institute.
Transcript
How do current payment models fare in managing the care needs of patients with diabetic kidney disease, and what room for improvement do you see here?
When it comes to diabetic kidney disease, diabetes is the most common cause of chronic kidney disease. And just like most other types of kidney disease, it's a very chronic course. It can be relatively slowly progressive, although it can advance in fits and starts, and it is a disease that truly benefits from earlier recognition.
We're at a stage right now where we actually have some fantastic kidney treatments for people with diabetic kidney disease. You have SGLT2 inhibitors, you have nonsteroidal mineralocorticoid receptor agonists, you still have your ACE inhibitors and ARBs in general blood pressure control and glycemic control, so there are a lot of things that we can do.
The limitation, again just like we're seeing throughout the chronic kidney disease space, is that these interventions have the greatest net effect if they're applied earlier. So our biggest limitation actually is a failure to detect kidney disease early on, even in people with diabetes who were universally recommended for screening, but also in people who have high blood pressure, people who have obesity, or even just about anybody because the prevalence of kidney disease is so high.
None of the systems that are in place right now are designed to detect early stage kidney disease and prevent something from happening 5, 10, 20 years down the road. I think that where we have the greatest need is in designing systems that are going to reward foresight and are going to reward true preventative care that's preventing something in the long-term, and educating patients and care partners and clinicians that we actually do have things in our armamentarium that can have benefits 2, 5, 10, 20 years down the road.
Frameworks for Advancing Health Equity: Urban Health Outreach
May 9th 2024In the series debut episode of "Frameworks for Advancing Health Equity," Mary Sligh, CRNP, and Chelsea Chappars, of Allegheny Health Network, explain how the Urban Health Outreach program aims to improve health equity for individuals experiencing homelessness.
Listen
Tackling Health Inequality: The Power of Education and Experience
April 30th 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. Welcome to our final episode of this limited series and our conversation with Janine Jelks-Seale, MSPPM, director of health equity at UPMC Health Plan.
Listen
Joanne Mizell: Lifestyle Modification Programs Take Holistic Aim at Metabolic Disease
May 1st 2024Joanne Mizell shares insurer strategies in addressing the escalating rates of metabolic diseases, highlighting the importance of holistic treatment methods like lifestyle modification programs, which integrate nutrition, physical activity, and community engagement.
Read More